Matches in Wikidata for { <http://www.wikidata.org/entity/Q91021917> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q91021917 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q91021917 description "scientific article published on 18 August 2018" @default.
- Q91021917 description "wetenschappelijk artikel" @default.
- Q91021917 description "наукова стаття, опублікована в серпні 2018" @default.
- Q91021917 name "Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome" @default.
- Q91021917 name "Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome" @default.
- Q91021917 type Item @default.
- Q91021917 label "Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome" @default.
- Q91021917 label "Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome" @default.
- Q91021917 prefLabel "Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome" @default.
- Q91021917 prefLabel "Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome" @default.
- Q91021917 P1433 Q91021917-D49E6DB1-652E-4C42-BD34-CB63B784C270 @default.
- Q91021917 P1476 Q91021917-8632B94E-F950-4A82-9765-4E13BEDDD71F @default.
- Q91021917 P2093 Q91021917-1F0BBF08-A8C4-406B-A068-25125CCACD86 @default.
- Q91021917 P2093 Q91021917-741CDB85-63E3-4E12-8CCD-59081AA3BB17 @default.
- Q91021917 P2093 Q91021917-AB674DEA-E97B-4B8B-BDDA-61CC7999F751 @default.
- Q91021917 P2093 Q91021917-FC0757F0-47F4-4624-BCC2-C580A6280B60 @default.
- Q91021917 P304 Q91021917-00B11408-7DC4-4646-9316-61AC16EACD4C @default.
- Q91021917 P31 Q91021917-A8C454CB-A08E-4F0D-8B25-27E02E097263 @default.
- Q91021917 P356 Q91021917-EC0D6440-8FD8-4C4B-B8A9-9467C5B5F8D2 @default.
- Q91021917 P433 Q91021917-9B9C4269-5895-4580-84FA-7CCED2428868 @default.
- Q91021917 P478 Q91021917-9F1FD499-C95F-4021-A8CE-1DBD470239E1 @default.
- Q91021917 P50 Q91021917-9EFE98D1-657D-42CC-921E-B0EB4715529B @default.
- Q91021917 P577 Q91021917-50704463-03EE-4D91-9C73-393C29881E8C @default.
- Q91021917 P698 Q91021917-1ED5D451-F4B8-4AAC-ABF4-79E5019B01A2 @default.
- Q91021917 P921 Q91021917-CD3EAD78-93C3-4C08-B338-F5CE9DC7D478 @default.
- Q91021917 P356 S10157-018-1628-5 @default.
- Q91021917 P698 30121800 @default.
- Q91021917 P1433 Q26842022 @default.
- Q91021917 P1476 "Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome" @default.
- Q91021917 P2093 "Akira Mizutani" @default.
- Q91021917 P2093 "Daishi Hirano" @default.
- Q91021917 P2093 "Koji Sakuraya" @default.
- Q91021917 P2093 "Toshiaki Shimizu" @default.
- Q91021917 P304 "244-250" @default.
- Q91021917 P31 Q13442814 @default.
- Q91021917 P356 "10.1007/S10157-018-1628-5" @default.
- Q91021917 P433 "2" @default.
- Q91021917 P478 "23" @default.
- Q91021917 P50 Q88417610 @default.
- Q91021917 P577 "2018-08-18T00:00:00Z" @default.
- Q91021917 P698 "30121800" @default.
- Q91021917 P921 Q504790 @default.